Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults

Am J Physiol. 1998 Jun;274(6):E1050-6. doi: 10.1152/ajpendo.1998.274.6.E1050.

Abstract

Growth hormone (GH) treatment of GH-deficient adults increases lean body mass. To investigate this anabolic effect of GH, body composition and postabsorptive and postprandial protein metabolism were measured in 12 GH-deficient adults randomized to placebo or GH treatment. Protein metabolism was measured after an infusion of [1-13C]leucine before and after a standard meal at 0 and 2 mo. After 2 mo, there was an increase in lean body mass in the GH group (P < 0. 05) but no change in the placebo group. In the postabsorptive state, there was increased nonoxidative leucine disappearance (NOLD; a measure of protein synthesis) and leucine metabolic clearance rate and decreased leucine oxidation in the GH group (P < 0.05) but no change in the placebo group. After the meal, there was an increase in NOLD and oxidation in all studies (P < 0.05), but the increase in NOLD, measured as area under the curve, was greater in the GH group (P < 0.05). This study clearly demonstrates for the first time that the increase in protein synthesis in the postabsorptive state after GH treatment of GH-deficient adults is maintained in the postprandial state.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Composition
  • C-Peptide / blood
  • Carbon Isotopes
  • Fatty Acids, Nonesterified / blood
  • Female
  • Food*
  • Human Growth Hormone / deficiency*
  • Human Growth Hormone / pharmacology*
  • Human Growth Hormone / therapeutic use
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Leucine
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Placebos
  • Protein Biosynthesis*

Substances

  • C-Peptide
  • Carbon Isotopes
  • Fatty Acids, Nonesterified
  • Placebos
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Leucine